Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,660 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis.
Roughead EE, Chan EW, Choi NK, Griffiths J, Jin XM, Lee J, Kimura M, Kimura T, Kubota K, Lai EC, Man KK, Nguyen TA, Ooba N, Park BJ, Sato T, Shin JY, Wang T, Wong IC, Yang YK, Pratt NL. Roughead EE, et al. Among authors: kimura m, kimura t. Expert Opin Drug Saf. 2016 Dec;15(12):1589-1595. doi: 10.1080/14740338.2016.1238071. Epub 2016 Sep 27. Expert Opin Drug Saf. 2016. PMID: 27645304
The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.
AsPEN collaborators; Andersen M, Bergman U, Choi NK, Gerhard T, Huang C, Jalbert J, Kimura M, Kimura T, Kubota K, Lai EC, Ooba N, Park BJ, Pratt N, Roughead EE, Sato T, Setoguchi S, Shin JY, Sundström A, Yang YH. AsPEN collaborators, et al. Among authors: kimura m, kimura t. Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):700-4. doi: 10.1002/pds.3439. Epub 2013 May 8. Pharmacoepidemiol Drug Saf. 2013. PMID: 23653370 No abstract available.
Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study.
Pratt N, Andersen M, Bergman U, Choi NK, Gerhard T, Huang C, Kimura M, Kimura T, Kubota K, Lai EC, Ooba N, Osby U, Park BJ, Sato T, Shin JY, Sundström A, Yang YH, Roughead EE. Pratt N, et al. Among authors: kimura m, kimura t. Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):915-24. doi: 10.1002/pds.3440. Epub 2013 May 21. Pharmacoepidemiol Drug Saf. 2013. PMID: 23696036
Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries.
Pratt N, Chan EW, Choi NK, Kimura M, Kimura T, Kubota K, Lai EC, Man KK, Ooba N, Park BJ, Sato T, Shin JY, Wong IC, Kao Yang YH, Roughead EE. Pratt N, et al. Among authors: kimura m, kimura t. Pharmacoepidemiol Drug Saf. 2015 Aug;24(8):858-64. doi: 10.1002/pds.3780. Epub 2015 Apr 22. Pharmacoepidemiol Drug Saf. 2015. PMID: 25907076 Free PMC article.
Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries.
Roughead EE, Chan EW, Choi NK, Kimura M, Kimura T, Kubota K, Lai EC, Man KK, Nguyen TA, Ooba N, Park BJ, Sato T, Shin JY, Wang T, Griffiths J, Wong IC, Yang YH, Pratt NL. Roughead EE, et al. Among authors: kimura m, kimura t. Drug Saf. 2015 Sep;38(9):823-31. doi: 10.1007/s40264-015-0318-4. Drug Saf. 2015. PMID: 26216600 Free PMC article.
A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T, Sai K, Tohkin M, Segawa K, Kimura M, Hori K, Kawakami J, Saito Y. Hanatani T, et al. Among authors: kimura m. Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):984-8. doi: 10.1002/pds.3603. Epub 2014 Mar 5. Pharmacoepidemiol Drug Saf. 2014. PMID: 24596340
Establishment of the MID-NET® medical information database network as a reliable and valuable database for drug safety assessments in Japan.
Yamaguchi M, Inomata S, Harada S, Matsuzaki Y, Kawaguchi M, Ujibe M, Kishiba M, Fujimura Y, Kimura M, Murata K, Nakashima N, Nakayama M, Ohe K, Orii T, Sueoka E, Suzuki T, Yokoi H, Takahashi F, Uyama Y. Yamaguchi M, et al. Among authors: kimura m. Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1395-1404. doi: 10.1002/pds.4879. Epub 2019 Aug 29. Pharmacoepidemiol Drug Saf. 2019. PMID: 31464008 Free PMC article.
The utilization and challenges of Japan's MID-NET® medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies.
Yamada K, Itoh M, Fujimura Y, Kimura M, Murata K, Nakashima N, Nakayama M, Ohe K, Orii T, Sueoka E, Suzuki T, Yokoi H, Ishiguro C, Uyama Y; MID-NET® project group. Yamada K, et al. Among authors: kimura m. Pharmacoepidemiol Drug Saf. 2019 May;28(5):601-608. doi: 10.1002/pds.4777. Epub 2019 Apr 3. Pharmacoepidemiol Drug Saf. 2019. PMID: 30945387
6,660 results